ASTERIAS BIOTHERAPEUTICS
Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellula... r immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.
ASTERIAS BIOTHERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2012-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.asteriasbiotherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(650) 433-2900
Email Addresses:
[email protected]
Total Funding:
16.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network Organization Schema Sitelinks Search Box JsDelivr
Similar Organizations
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Burst Biologics
Burst Biologics is a research biotechnology company, develops groundbreaking products in the cutting-edge field of regenerative medicine.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Sensei Biotherapeutics
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Founder
Stock Details
Investors List
Pedro Lichtinger
Pedro Lichtinger investment in Series B - Asterias Biotherapeutics
Official Site Inspections
http://www.asteriasbiotherapeutics.com
- Host name: ip222.ip-54-39-87.net
- IP address: 54.39.87.222
- Location: Montreal Canada
- Latitude: 45.5063
- Longitude: -73.5794
- Timezone: America/Toronto
- Postal: H3A
More informations about "Asterias Biotherapeutics"
Asterias Biotherapeutics - Crunchbase Company Profile & Funding
Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat …See details»
Asterias Biotherapeutics - LinkedIn
Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary cell therapy programs are based on its immunotherapy …See details»
Asterias Biotherapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Asterias Biotherapeutics, Inc. of Alameda, CA. Get the latest business insights from Dun & Bradstreet.See details»
Asterias Biotherapeutics Inc. (AST): Our New Investor
Sep 24, 2012 SECTOR: Health Care INDUSTRY: Health Care SUB-INDUSTRY: Biotech & Canadian pharma FOUNDED: 09/24/2012 ADDRESS: 6300 Dumbarton Circle Fremont, CA …See details»
Asterias Biotherapeutics - Craft
Mar 11, 2019 Asterias Biotherapeutics, Inc., a development-stage biotechnology company, focuses on the development of therapeutic products to treat neurology, oncology, cardiology, …See details»
Board of Directors - asteriasbiotherapeutics.com
Asterias Biotherapeutics. Front Page; Company; Products; How To Order; Investors. Corporate Governance; Board of DirectorsSee details»
Company Asterias Biotherapeutics Inc - MarketScreener.com
Asterias Biotherapeutics Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nyse: AST | NyseSee details»
Asterias Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Asterias Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 10 news, and 3 literature, Drug:VAC-1(Wuchan Zhongda Geron), GRNCM-1, …See details»
Asterias Biotherapeutics - VentureRadar
Website: https://asteriasbiotherapeutics.com/ Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine.See details»
Asterias Biotherapeutics - Products, Competitors, Financials, …
Asterias Biotherapeutics is a biotechnology company focused on the field of regenerative medicine, developing proprietary cell therapy programs that are based on its pluripotent stem …See details»
Asterias Biotherapeutics - PitchBook
Asterias Biotherapeutics General Information Description. Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of …See details»
Asterias Biotherapeutics - Ownership and Business Overview
Www.asteriasbiotherapeutics.com. Profile Investors (1) Analytics Asterias Biotherapeutics, Inc. is a biotechnology company engages in the emerging field of regenerative medicine. The …See details»
Asterias Biotherapeutics - Overview, News & Similar companies ...
Popular Searches Asterias Biotherapeutics Inc Asterias Biotherapeutics Asteriasbiotherapeutics SIC Code 28,283 NAICS Code 32,325 Show more. Similar Companies to Asterias …See details»
Asterias Biotherapeutics to merge with BioTime - Pharmaceutical …
Mar 24, 2022 Asterias Biotherapeutics to merge with BioTime. US-based biotechnology firms BioTime and Asterias Biotherapeutics have entered into a definitive merger agreement to form …See details»
Asterias Biotherapeutics Company Overview, Contact Details ...
Asteriasbiotherapeutics invests into assets: manufacturing facility. manufacturing facility to Asterias Biotherapeutics, they contacted MAI Construction to execute the tenant …See details»
BioTime Announces Closing of Acquisition of Asterias …
Mar 11, 2019 ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American and TASE: BTX), today announced the closing of its previously reported acquisition of Asterias …See details»
Corporate Governance - asteriasbiotherapeutics.com
Proper distribution of responsibilities and rights within our company is always a priority. Canadian Neighbor Pharmacy is fully committed to good corporate governance practices, which means …See details»
Company Asterias Biotherapeutics Inc Börse Stuttgart
Asterias Biotherapeutics Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Börse Stuttgart ...See details»
Asterias Biotherapeutics – A Global Leader In Regenerative Medicine
Mar 15, 2018 Asterias Biotherapeutics Fourth Results Conference Call March 15, 2018 5:00pm ET To access the live webcast, go to http://www.wsw.com/webcast/cc/astb20See details»
Inside the futuristic biotech startup Cellares that’s building a cure ...
Mar 24, 2025 Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»